These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 24248942
1. High-density lipoprotein particle subclass heterogeneity and incident coronary heart disease. Akinkuolie AO, Paynter NP, Padmanabhan L, Mora S. Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):55-63. PubMed ID: 24248942 [Abstract] [Full Text] [Related]
9. Relation of black race between high density lipoprotein cholesterol content, high density lipoprotein particles and coronary events (from the Dallas Heart Study). Chandra A, Neeland IJ, Das SR, Khera A, Turer AT, Ayers CR, McGuire DK, Rohatgi A. Am J Cardiol; 2015 Apr 01; 115(7):890-4. PubMed ID: 25661572 [Abstract] [Full Text] [Related]
11. Associations of lipoprotein subclasses with risk of all-cause and cardiovascular disease mortality in individuals with type 2 diabetes: A prospective cohort study. Li R, Chen JX, Lu Q, Geng TT, Xia PF, Wang Y, Chen LK, Shan ZL, Pan A, Liu G. Diabetes Obes Metab; 2023 Nov 01; 25(11):3259-3267. PubMed ID: 37492984 [Abstract] [Full Text] [Related]
17. Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events. Mora S, Buring JE, Ridker PM. Circulation; 2014 Feb 04; 129(5):553-61. PubMed ID: 24345402 [Abstract] [Full Text] [Related]
18. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Mora S, Otvos JD, Rifai N, Rosenson RS, Buring JE, Ridker PM. Circulation; 2009 Feb 24; 119(7):931-9. PubMed ID: 19204302 [Abstract] [Full Text] [Related]
19. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin). Khera AV, Demler OV, Adelman SJ, Collins HL, Glynn RJ, Ridker PM, Rader DJ, Mora S. Circulation; 2017 Jun 20; 135(25):2494-2504. PubMed ID: 28450350 [Abstract] [Full Text] [Related]